You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Related Medications Videos on Diabetes Health TV
Close Encounter - A Profile of a Diabetes Patient and Business Insider
Todd speaks about Levemir
Nipro Diabetes Systems Introduces The Amigo®
Popular Pharmacy Articles
Highly Recommended Pharmacy Articles
Bayer Diabetes Care has recalled 230,000 bottles of Contour TS test strips after finding that the strips resulted in blood glucose readings 5 to 17 percent higher than actual levels.
0 comments - Dec 29, 2007 -
In July, I flew from New York City to Phoenix to meet my new book agent. (Trust me, I would not have deliberately sought out 100-degree weather without good reason.) Always thinking ahead, I decided to bring along a fancy new bag specially insulated to keep my insulin cool. Alas, either the bag failed me, or I failed the bag.
3 comments - Nov 25, 2007 -
Los Angeles Times columnist and newly diagnosed type 1 David Lazarus is becoming quite an advocate for people with diabetes.
4 comments - Nov 10, 2007 -
The FDA has spoken: the heart risk warnings on labels of Avandia (rosiglitazone) and Actos (pioglitazone) will now be surrounded by an emphatic black outline known as a black box. Black boxes will also be added to the warnings on Avandaryl (rosiglitazone and glimepiride), Avandamet (rosiglitazone and metformin), and Duetact (pioglitazone and glimepiride).
3 comments - Oct 31, 2007 -
According to Greek researchers, Actos and Avandia were behind a tripling of the cost of medicines used to treat Athenians with type 2 diabetes over the past eight years.
0 comments - Oct 10, 2007 -
The September 2007 Journal of the American Medical Association (JAMA) has published two new studies, one a meta-analysis of Avandia (rosiglitazone) and the other a meta-analysis of Actos (pioglitazone).
0 comments - Oct 5, 2007 -
Americans spend 275 billion dollars on prescription medicines every single year, sixty percent of it on generics. But in the next five years, the twenty-year patents are going to expire on enough brand-name medicines to account for about 60 billion dollars of that total. And the generics that spring up to replace those drugs will be thirty to eighty percent cheaper.
3 comments - Aug 26, 2007 -
According to a literature review and survey of 132 Canadian pharmacists, 47 percent of pharmacists have encountered an adverse interaction between a natural health product and a drug.
0 comments - Aug 13, 2007 -
On December 13, 2005, Keith Scofield visited a Wal-Mart pharmacy in Frederick, Maryland, and ordered over-the-counter Humulin R (u-100). Instead, he was allegedly given Humulin R (u-500), a prescription drug that contains five times the insulin of the requested medication.
3 comments - Aug 7, 2007 -
On July 30, 2007, a Food and Drug Administration (FDA) panel voted 22 to 1 to keep Avandia on the market, right after agreeing by a vote of 20 to 3 that Avandia does increase heart risks. Now the FDA will decide what kind of warning should appear on the Actos and Avandia labels. It has already called for a black box warning, the sternest possible, on Avandia.
0 comments - Aug 1, 2007 -
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.